Name | Number of supported studies | Average coverage | |
---|---|---|---|
transit amplifying cell | 3 studies | 46% ± 24% |
Insufficient scRNA-seq data for expression of POLQ at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 96% | 492.17 | 1740 / 1809 | 83% | 3.00 | 394 / 472 |
stomach | 60% | 128.33 | 217 / 359 | 95% | 5.37 | 272 / 286 |
intestine | 60% | 229.40 | 575 / 966 | 94% | 4.76 | 498 / 527 |
lung | 70% | 105.43 | 403 / 578 | 84% | 4.81 | 965 / 1155 |
esophagus | 49% | 325.34 | 704 / 1445 | 100% | 10.30 | 183 / 183 |
bladder | 43% | 31.38 | 9 / 21 | 94% | 4.97 | 475 / 504 |
breast | 50% | 46.69 | 228 / 459 | 86% | 3.45 | 957 / 1118 |
uterus | 18% | 20.28 | 30 / 170 | 98% | 8.40 | 448 / 459 |
ovary | 20% | 20.73 | 36 / 180 | 90% | 3.04 | 388 / 430 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.54 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.00 | 1 / 1 |
spleen | 100% | 389.77 | 240 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 7.48 | 28 / 29 |
adrenal gland | 77% | 95.16 | 199 / 258 | 17% | 0.42 | 38 / 230 |
pancreas | 12% | 9.55 | 39 / 328 | 63% | 1.70 | 113 / 178 |
heart | 64% | 56.48 | 550 / 861 | 0% | 0 | 0 / 0 |
brain | 26% | 19.04 | 694 / 2642 | 33% | 0.86 | 231 / 705 |
liver | 19% | 33.99 | 43 / 226 | 36% | 0.84 | 147 / 406 |
adipose | 55% | 57.96 | 662 / 1204 | 0% | 0 | 0 / 0 |
prostate | 34% | 32.88 | 84 / 245 | 12% | 0.25 | 62 / 502 |
peripheral blood | 44% | 880.08 | 413 / 929 | 0% | 0 | 0 / 0 |
kidney | 19% | 25.89 | 17 / 89 | 14% | 0.29 | 126 / 901 |
thymus | 15% | 16.05 | 96 / 653 | 14% | 0.67 | 83 / 605 |
blood vessel | 16% | 13.40 | 208 / 1335 | 0% | 0 | 0 / 0 |
muscle | 13% | 9.68 | 103 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032508 | Biological process | DNA duplex unwinding |
GO_0051260 | Biological process | protein homooligomerization |
GO_0006281 | Biological process | DNA repair |
GO_0042276 | Biological process | error-prone translesion synthesis |
GO_0006302 | Biological process | double-strand break repair |
GO_0006974 | Biological process | DNA damage response |
GO_0097681 | Biological process | double-strand break repair via alternative nonhomologous end joining |
GO_2000042 | Biological process | negative regulation of double-strand break repair via homologous recombination |
GO_0031297 | Biological process | replication fork processing |
GO_0006278 | Biological process | RNA-templated DNA biosynthetic process |
GO_0016446 | Biological process | somatic hypermutation of immunoglobulin genes |
GO_0006284 | Biological process | base-excision repair |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0090734 | Cellular component | site of DNA damage |
GO_0005829 | Cellular component | cytosol |
GO_0035861 | Cellular component | site of double-strand break |
GO_0003887 | Molecular function | DNA-directed DNA polymerase activity |
GO_0051575 | Molecular function | 5'-deoxyribose-5-phosphate lyase activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0003964 | Molecular function | RNA-directed DNA polymerase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0003678 | Molecular function | DNA helicase activity |
GO_0017116 | Molecular function | single-stranded DNA helicase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0000014 | Molecular function | single-stranded DNA endodeoxyribonuclease activity |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0003684 | Molecular function | damaged DNA binding |
Gene name | POLQ |
Protein name | DNA polymerase theta (DNA polymerase eta) [Includes: Helicase POLQ (EC 3.6.4.12); DNA polymerase POLQ (EC 2.7.7.7) (RNA-directed DNA polymerase POLQ) (EC 2.7.7.49)] DNA polymerase theta PRO0327 (Polymerase (DNA directed), theta, isoform CRA_c) DNA helicase (EC 3.6.4.12) |
Synonyms | hCG_2022564 POLH |
Description | FUNCTION: Low-fidelity DNA polymerase with a helicase activity that promotes microhomology-mediated end-joining (MMEJ), an alternative non-homologous end-joining (NHEJ) machinery required to repair double-strand breaks in DNA during mitosis . MMEJ is an error-prone repair pathway that produces deletions of sequences from the strand being repaired and promotes genomic rearrangements, such as telomere fusions, some of them leading to cellular transformation . MMEJ is required during mitosis to repair persistent double-strand breaks that originate in S-phase . Although error-prone, MMEJ protects against chromosomal instability and tumorigenesis (By similarity). The polymerase acts by binding directly the 2 ends of resected double-strand breaks, allowing microhomologous sequences in the overhangs to form base pairs . It then extends each strand from the base-paired region using the opposing overhang as a template . Requires partially resected DNA containing 2 to 6 base pairs of microhomology to perform MMEJ . The polymerase lacks proofreading activity and is highly promiscuous: unlike most polymerases, promotes extension of ssDNA and partial ssDNA (pssDNA) substrates . When the ends of a break do not contain terminal microhomology must identify embedded complementary sequences through a scanning step . Also shows endonuclease activity, which is required to trim the 3' ends before synthesis can occur, thereby preventing non-paired tails . Also acts as a DNA helicase, promoting dissociation of the replication protein A complex (RPA/RP-A), composed of RPA1, RPA2 and RPA3, from resected double-strand breaks to allow their annealing and subsequent joining by MMEJ . Removal of RPA/RP-A complex proteins prevents RAD51 accumulation at resected ends, thereby inhibiting homology-recombination repair (HR) pathway . Also shows RNA-directed DNA polymerase activity to mediate DNA repair in vitro; however this activity needs additional evidence in vivo . May also have lyase activity . Involved in somatic hypermutation of immunoglobulin genes, a process that requires the activity of DNA polymerases to ultimately introduce mutations at both A/T and C/G base pairs (By similarity). POLQ-mediated end joining activity is involved in random integration of exogenous DNA hampers . . |
Accessions | A0A804HJJ9 O75417 Q96SE4 ENST00000683498.1 ENST00000264233.6 [O75417-1] Q9UI68 |